Signals Inbox·July 18, 2026·Defense Tech
Is Anduril really worth its valuation today?
Anduril looks modestly overvalued at $61 billion today, but its real weakness is not the multiple. It is how much of the price still depends on contracts converting, factories scaling and Lattice becoming a true platform.
We track defense tech daily. Want the market signals in your inbox?
Send me the signals →No. Anduril is modestly overvalued at $61 billion based on the evidence visible today, although the price is much closer to defensible than the headline suggests. Our base case reaches $55.1 billion, only 9.7% below the observed valuation.
Current revenue, firm contracts, operational products and industrial capacity support about $29.4 billion, or 48.2%, of the valuation. Explicit future options add another $14.5 billion, leaving a $23.7 billion premium that still has to be earned.
The contract headlines are much bigger than the secured economics. Anduril is linked to roughly $25 billion of announced value, but only $2.02 billion is publicly identifiable as firm.
The product portfolio is real and unusually broad: 96% of its 25 product families have been tested and 76% have been selected or contracted. Scale is the weaker part, with only 8% showing repeat orders, 8% produced at scale and one manufacturing site disclosing a verified current output rate.
Lattice gives Anduril a credible platform story because it touches 24 product families and 12 customer groups. But only 27.8% of its moat components have meaningful independent validation, so the valuation still assumes software economics that public evidence has not proved.
Interested in defense tech?We can send you all the signals
Send me the signals → Delivered straight to your inboxThe Anduril Valuation Proof Map
The Anduril Valuation Proof Map tests how much of Anduril’s $61 billion valuation is supported by evidence visible today.
It combines 58 indicators across revenue, contracts, products, deployments, major programmes, manufacturing, Lattice, customers and valuation. Anduril scores 54.3 out of 100 overall.
Our central finding is that current evidence supports approximately $29.4 billion, or 48.2%, of the valuation. The remaining 51.8% depends on future growth, programme conversion, manufacturing scale and stronger Lattice economics.
Anduril Valuation Proof Map: 58 indicators behind the $61 billion valuation
| # | Indicator | Dimension | Result | Calculation basis | Score | Evidence | Confidence | What it means |
|---|---|---|---|---|---|---|---|---|
| 1 | Observed valuation | Valuation | $61.0bn | Series H post-money valuation | 48.2 | High | High | This is the price the evidence must justify. |
| 2 | Latest actual revenue | Valuation | $2.2bn | Media-reported actual | 48.2 | High | High | The proven revenue base is already substantial. |
| 3 | Latest forward revenue | Valuation | $4.3bn | Media forecast, not actual | 48.2 | Medium | Medium | The valuation relies heavily on this forecast landing. |
| 4 | Valuation / latest actual revenue | Valuation | 27.7× | Equity value / trailing revenue | 48.2 | High | High | The trailing multiple is extreme for defense manufacturing. |
| 5 | Valuation / forward revenue | Valuation | 14.2× | Equity value / forward estimate | 48.2 | Medium | Medium | Forecast growth makes the price less exceptional. |
| 6 | Capital raised / valuation | Valuation | 18.5% | Disclosed equity / post-money value | 48.2 | High | High | Investors have funded almost one-fifth of the valuation. |
| 7 | Latest historical revenue growth | Revenue | 120.0% | Latest year / previous year | 30.4 | Medium | Medium | Revenue more than doubled from an already meaningful base. |
| 8 | Forecast revenue growth | Revenue | 95.5% | Forecast / latest actual revenue | 30.4 | Medium | Medium | Anduril must almost double revenue again. |
| 9 | Software revenue share midpoint | Revenue | 10.0% | Evidence-based range midpoint | 30.4 | Low | Low | Public evidence does not support a software-heavy mix. |
| 10 | Recurring revenue share midpoint | Revenue | 17.5% | No ARR disclosure | 30.4 | Low | Low | Recurring software economics remain largely unproven. |
| 11 | Production revenue share midpoint | Revenue | 55.0% | Evidence-based classification | 30.4 | Medium | Medium | Production contracts appear to drive most revenue. |
| 12 | US government revenue share midpoint | Revenue | 80.0% | Directional programme mix | 30.4 | Medium | Medium | The business remains highly tied to US procurement. |
| 13 | Backlog coverage | Revenue | N/A | Backlog not publicly disclosed | 30.4 | High | High | A major valuation input remains unavailable. |
| 14 | Total announced headline ceiling | Contracts | $25.00bn | Includes ceilings and potential value | 48.0 | High | High | Headlines are dominated by maximum contract values. |
| 15 | Firm committed value identified | Contracts | $2.02bn | Publicly identifiable firm value | 48.0 | Medium | Medium | Only a small share of announced value is secured. |
| 16 | Firm value / headline value | Contracts | 8.1% | Contract Reality Funnel | 48.0 | Medium | Medium | Only eight cents of each headline dollar is firm. |
| 17 | Customer-confirmed firm value share | Contracts | 87.8% | Customer confirmations | 48.0 | Medium | Medium | Most identified firm value has credible confirmation. |
| 18 | Firm production-contract share | Contracts | 23.5% | Production value / firm value | 48.0 | Medium | Medium | Most firm value is not yet full production work. |
| 19 | Contract-to-deployment conversion | Contracts | 72.7% | Public operational status | 48.0 | Low | Low | Most firm contracts have reached some operational use. |
| 20 | Material products / families | Products | 25 products | Variants consolidated | 65.6 | High | High | Anduril has built an unusually broad portfolio. |
| 21 | Average product maturity | Products | 6.6/10 | Common ten-stage scale | 65.6 | Medium | Medium | The average product is contracted but not fully scaled. |
| 22 | Tested share | Products | 96.0% | Maturity stage four or above | 65.6 | Medium | Medium | Almost every material product has been tested. |
| 23 | Selected / contracted share | Products | 76.0% | Maturity stage six or above | 65.6 | Medium | Medium | Three-quarters have received customer selection or contracts. |
| 24 | Delivered share | Products | 48.0% | Maturity stage seven or above | 65.6 | Medium | Medium | Less than half have clear delivery evidence. |
| 25 | Operationally deployed share | Products | 36.0% | Maturity stage eight or above | 65.6 | Medium | Medium | Only around one-third are operationally deployed. |
| 26 | Repeat ordered share | Products | 8.0% | Maturity stage nine or above | 65.6 | Medium | Medium | Repeat-order evidence remains rare. |
| 27 | Produced-at-scale share | Products | 8.0% | Strict maturity stage ten | 65.6 | Medium | Medium | Only two product families meet the scale test. |
| 28 | Acquired-origin product share | Products | 24.0% | Acquired and co-developed products | 65.6 | Medium | Medium | Acquisitions created meaningful portfolio breadth. |
| 29 | Independently measured performance share | Operations | 0.0% | Strict measured-evidence test | 62.5 | High | High | No product has a public standardized performance benchmark. |
| 30 | Material programmes | Programmes | 16 programmes | Wins, active cases and setbacks | 54.3 | High | High | The programme pipeline can materially change Anduril’s scale. |
| 31 | Programmes won / selected | Programmes | 8 programmes | Outcome classification | 54.3 | Medium | Medium | Half of the major programmes are already won or selected. |
| 32 | Delayed, lost or setback programmes | Programmes | 3 programmes | Negative evidence retained | 54.3 | Medium | Medium | Anduril’s record includes meaningful setbacks. |
| 33 | Resolved programme win rate | Programmes | 72.7% | Wins / resolved outcomes | 54.3 | Low | Low | Anduril has a strong competitive record so far. |
| 34 | Firm secured programme value | Programmes | $1.38bn | Current identified firm value | 54.3 | Medium | Medium | Secured programme value remains modest beside $61 billion. |
| 35 | Remaining potential programme pipeline | Programmes | $51.80bn | Potential value, not backlog | 54.3 | Low | Low | The opportunity set is large but highly conditional. |
| 36 | Probability-weighted programme pipeline | Programmes | $21.89bn | Explicit stage probabilities | 54.3 | Low | Low | The adjusted pipeline is meaningful, not guaranteed. |
| 37 | Top-three programme concentration | Programmes | 82.0% | Weighted pipeline concentration | 54.3 | Low | Low | Three opportunities drive most future programme value. |
| 38 | Material manufacturing sites / lines | Manufacturing | 10 sites | Site and line count | 56.7 | Medium | Medium | Anduril has assembled a broad industrial footprint. |
| 39 | Operational or partial sites | Manufacturing | 9 sites | Includes prototype operations | 56.7 | Medium | Medium | Most facilities are operating at least partially. |
| 40 | Sites with verified current output | Manufacturing | 1 site | Numeric production evidence | 56.7 | Medium | Medium | Verified factory output remains a major gap. |
| 41 | Overall Lattice Moat Score | Lattice | 63.3/100 | Seven evidence dimensions | 63.3 | Medium | Medium | Lattice is differentiated, but not yet dominant. |
| 42 | Moat components with customer evidence | Lattice | 83.3% | Customer validation available | 63.3 | Medium | Medium | Most Lattice claims have some customer support. |
| 43 | Moat components with independent evidence | Lattice | 27.8% | Independent validation | 63.3 | Low | Low | Fewer than one-third have independent validation. |
| 44 | Company-only or inferred moat share | Lattice | 27.8% | Weak-evidence classification | 63.3 | Medium | Medium | A meaningful share still relies on claims or inference. |
| 45 | Distinct products using Lattice | Lattice | 24 products | Core, integrated or related | 63.3 | Medium | Medium | Lattice connects almost the entire Anduril portfolio. |
| 46 | Customer groups with Lattice exposure | Lattice | 12 customers | Not standalone software customers | 63.3 | Medium | Medium | Adoption is broad, but software economics remain unclear. |
| 47 | Confirmed paying customers | Customers | 10 customers | Public-source minimum | 53.9 | Medium | Medium | The customer base is real but relatively small. |
| 48 | Repeat-customer ratio | Customers | 100.0% | Qualitative repeat evidence | 53.9 | Low | Low | Every confirmed payer shows repeat engagement. |
| 49 | US customer share | Customers | 79.4% | Estimated normalized shares | 53.9 | Low | Low | Roughly four-fifths of demand comes from the US. |
| 50 | International customer share | Customers | 20.6% | Estimated normalized shares | 53.9 | Low | Low | International demand remains secondary. |
| 51 | Top-customer share | Customers | 25.2% | Estimated normalized shares | 53.9 | Low | Low | No single customer appears existentially dominant. |
| 52 | Top-three customer share | Customers | 49.1% | Estimated normalized shares | 53.9 | Low | Low | Three customers represent around half of demand. |
| 53 | Customer HHI | Customers | 0.128 | Estimated customer shares | 53.9 | Low | Low | Customer concentration is moderate rather than extreme. |
| 54 | Current-evidence subtotal | Valuation Bridge | $29.4bn | Revenue, contracts, products and sites | 48.2 | Low | Low | Current evidence supports less than half the valuation. |
| 55 | Future-option subtotal | Valuation Bridge | $14.5bn | Lattice, pipeline and strategic premium | 48.2 | Low | Low | Future opportunities add meaningful but uncertain value. |
| 56 | Residual to observed valuation | Valuation Bridge | $23.7bn | Unexplained bridge residual | 48.2 | Low | Low | A large premium remains beyond observable evidence. |
| 57 | Current-evidence support share | Valuation Bridge | 48.2% | Current subtotal / valuation | 48.2 | Low | Low | The existing business supports about forty-eight cents per dollar. |
| 58 | Execution-dependent share | Valuation Bridge | 51.8% | Remaining valuation share | 48.2 | Low | Low | More than half the price depends on future execution. |
Interested in defense tech?We can send you all the signals
Send me the signals → Delivered straight to your inboxQ1What exactly are investors paying $61 billion for?
Investors are paying for a credible defense company today and a potential next-generation prime tomorrow.
Our valuation bridge attributes about $29.4 billion to evidence already visible in revenue, firm contracts, operational products and industrial capacity. That equals 48.2% of the observed valuation.
We allocate another $14.5 billion to explicit future options, including Lattice, the probability-weighted programme pipeline and Anduril’s strategic scarcity. After a 15% overlap and execution haircut, the illustrative bridge falls to $37.3 billion, leaving a $23.7 billion residual to the market valuation.
That residual shows what the price assumes: the $4.3 billion forward-revenue estimate must land, major programme ceilings must convert into funded orders, Arsenal-1 must become a real mass-production system, and Lattice must develop economics closer to a platform than to software bundled into hardware contracts.
Q2How expensive is Anduril compared with other defense companies?
Anduril is extremely expensive compared with listed defense companies, but not unusually expensive compared with private defense-tech peers on forward revenue.
The company trades at 27.7× its latest reported actual revenue and 14.2× its forward revenue estimate. The trailing multiple is far above AeroVironment at 3.6×, Kratos at 6.1× and established primes generally between 1.6× and 10×.
The private comparison changes the picture. Shield AI is valued around 21× forward revenue, Helsing around 32× and Saronic around 26.7×. Excluding Anduril, the private-peer median is approximately 23.8×, meaning Anduril’s 14.2× forward multiple is roughly 40% lower.
Anduril revenue multiples versus defense and defense-tech peers
| # | Company | Business type | Revenue basis | Revenue multiple |
|---|---|---|---|---|
| 1 | Anduril | Integrated autonomy, hardware and software | Media-reported actual | 27.7× trailing; 14.2× forward |
| 2 | Shield AI | Autonomy software and aircraft | Media forward estimate | 21.0× |
| 3 | Helsing | AI software and autonomous systems | Media forward estimate | 32.0× |
| 4 | Quantum Systems | Small UAS and autonomy | Media forward estimate | 8.5× |
| 5 | Saronic | Autonomous surface vessels | Derived / media forecast | 26.7× |
| 6 | Palantir | Data platform and AI software | Filed actual | 76.0× |
| 7 | AeroVironment | UAS, loitering munitions and space/cyber | Filed actual | 3.6× |
| 8 | Kratos Defense | Target drones, propulsion and autonomous aircraft | Filed actual | 6.1× |
| 9 | Lockheed Martin | Multi-domain prime contractor | Filed actual | 1.6× |
| 10 | Northrop Grumman | Aerospace, space and mission systems | Filed actual | 1.8× |
| 11 | Saab | Sensors, aircraft, missiles and naval systems | Filed actual / approximate | 4.0× |
| 12 | Hensoldt | Sensors, radars and optronics | Filed actual / approximate | 4.6× |
| 13 | Rheinmetall | Weapons, ammunition and vehicles | Filed actual / approximate | 10.0× |
Q3Is Anduril’s revenue as strong as it looks?
Anduril’s revenue growth is genuinely exceptional, but its revenue quality is weaker than the headline growth suggests.
Reported revenue increased from roughly $1.0 billion to $2.2 billion, a 120% increase. The forward estimate reaches $4.3 billion, requiring another 95.5% increase. Few defense companies are growing at anything close to that speed.
The composition matters. Our evidence-based midpoint estimates put hardware at about 65% of revenue, production contracts at 55%, development and prototype work at 22.5%, and software at only 10%. Recurring revenue appears closer to 17.5% than to a true software-platform mix.
The business also remains highly exposed to government procurement. We estimate that US government customers represent about 80% of revenue, while international governments contribute around 20%. Acquired products and capabilities may account for approximately one-quarter of revenue, but Anduril does not disclose an organic-growth split.
We track defense tech daily. Want the market signals in your inbox?
Send me the signals →Q4Is Anduril’s $20 billion Army contract really worth $20 billion?
No. Anduril’s $20 billion Army agreement is a maximum contract ceiling, not $20 billion of secured backlog or guaranteed revenue.
Across our full contract register, Anduril is connected to approximately $25.0 billion of announced headline value. Only $2.02 billion, or 8.1%, is publicly identifiable as firm and initially obligated. The remaining $22.99 billion is optional, potential or ceiling value.
The Army enterprise agreement is the clearest example. It creates a ten-year purchasing vehicle with a $20 billion maximum, but our dataset identifies no initial firm obligation under the headline award. Future task orders still need to be issued and funded.
The underlying contract evidence is still credible. About 87.8% of identified firm value has customer confirmation, 99.2% was won through competed processes, and 72.7% of firm contracts have reached some form of operational deployment. However, only 23.5% of firm value is clearly attached to production contracts rather than frameworks, development work or prototypes.
Q5Is Anduril winning the biggest defense programmes?
Yes. Anduril is winning major defense programmes, but three opportunities still drive most of the upside.
We identified 16 material programmes. Eight are already won or selected, while three have experienced a delay, loss or material setback. Among resolved outcomes, Anduril’s win rate is 72.7%.
The wins are meaningful. Anduril secured a position in the Air Force’s Collaborative Combat Aircraft programme, an A$1.7 billion Ghost Shark programme in Australia and major opportunities around Barracuda, Army command and control, and counter-UAS systems.
However, these programmes contain only $1.38 billion of identified firm value, compared with $51.8 billion of remaining potential value. Applying explicit stage-based probabilities reduces the pipeline to $21.9 billion.
CCA, Barracuda and the Army enterprise framework represent approximately 82% of the probability-weighted pipeline. Anduril is winning the programmes that matter, but the investment case remains highly sensitive to whether those three opportunities reach full production.
Q6Can Anduril actually manufacture at the scale it promises?
Anduril has built a credible industrial footprint, but public evidence of mass output remains thin.
We identified 10 material manufacturing sites or product lines, of which nine are operational or partially operational. This is much stronger than a typical defense startup with outsourced prototypes and no internal production base.
The problem is conversion. Only one site discloses a verified current production rate, and only two disclose actual deliveries. Six facilities are still planned, ramping or transitioning. Four carry negative execution evidence, including test incidents, safety concerns, quality issues or delays.
The Bolt line has an installed annualized rate of about 1,200 units against a target of 2,100, or 57.1% of announced capacity. The ALTIUS line reports hundreds of cumulative deliveries, while the Ghost Shark facility has produced its first factory vehicle after three earlier prototypes.
Arsenal-1 is the central valuation bet. Anduril is investing about $911 million, has committed more than 4,000 jobs and describes capacity in the tens of thousands of mixed systems annually. As of now, no verified mass output has been disclosed.
Anduril can build products. It still has to prove it can operate several high-volume lines simultaneously while maintaining cost, safety, quality and delivery performance.
Interested in defense tech?We can send you all the signals
Send me the signals → Delivered straight to your inboxBoeing is turning a 500-pound JDAM into a cruise missile
Ursa Major is going public with $350M to scale hypersonics
The U.S. Army is testing 70,000-foot balloons over Poland
Q7Is Anduril’s Lattice a real moat or just integration software?
Lattice is a real and differentiated integration platform. A Palantir-like software moat is still unproven.
Our Lattice Moat Score is 63.3 out of 100. Its strongest evidence comes from deployment breadth, switching-cost relevance and the difficulty of reproducing a platform already integrated across many military systems.
Lattice touches 24 of Anduril’s 25 product families and appears across 12 customer groups. Each additional sensor, interceptor, aircraft or underwater system can therefore increase the usefulness of the same command-and-control layer.
The economic proof is weaker. Recurring software economics score only 28.9, while independently measurable performance scores 38.9. Although 83.3% of Lattice moat components have some customer evidence, only 27.8% have meaningful independent validation.
The key unanswered question is whether customers pay separately and repeatedly for Anduril’s Lattice software, or whether Lattice mainly helps Anduril win larger hardware and integration contracts. The second outcome remains valuable, but it deserves a lower valuation multiple than a high-margin standalone software platform.
Q8Is Anduril too dependent on the Pentagon?
Yes. Anduril remains heavily dependent on the US government, although no single customer appears large enough to threaten the company alone.
Our public-source minimum identifies 10 confirmed paying customers, with repeat engagement across all ten. This is a stronger customer base than most private defense startups.
The estimated value mix remains concentrated. US customers represent about 79.4%, the Department of Defense alone about 74.3%, and international customers only 20.6%. The US Army is the largest estimated customer at 25.2%, while the top three account for 49.1%.
The resulting customer HHI is 0.128, a moderate level of concentration. Anduril is not dependent on one contract, but it remains dependent on one procurement ecosystem, one national budget and a relatively small group of military buyers.
Q9Can Anduril realistically grow into a $61 billion valuation?
Anduril can grow into $61 billion without becoming a traditional defense prime, but only if it preserves a premium platform multiple.
At a mature-prime multiple of 2× revenue, Anduril would need $30.5 billion of annual revenue. Reaching that within five years would require 69.2% annual growth, roughly $35.1 billion of yearly order intake and a $45.8 billion backlog.
At a public defense-technology multiple of 5×, the required revenue falls to $12.2 billion, but the five-year growth requirement remains 40.9% annually. An 8× integrated-manufacturer multiple requires $7.6 billion and 28.2% annual growth.
The valuation becomes achievable at platform multiples. A 12× multiple requires $5.08 billion of revenue and 18.2% five-year growth. A 16× strategic-platform multiple requires only $3.81 billion, below the reported $4.3 billion forward estimate.
That is the bet. Anduril does not need to become Lockheed Martin to justify $61 billion. However, it needs to prove that its hardware-heavy business deserves a durable 12× to 16× revenue multiple through recurring Lattice economics, high growth and strategic scarcity.
Revenue required to support Anduril’s $61 billion valuation
| Future identity | Revenue multiple | Revenue required | Five-year CAGR | Operating requirement |
|---|---|---|---|---|
| Traditional defense prime | 2× | $30.50bn | 69.2% | Extensive backlog and mature industrial scale |
| Public defense-technology company | 5× | $12.20bn | 40.9% | High growth with mixed hardware and software economics |
| High-growth integrated manufacturer | 8× | $7.62bn | 28.2% | Rapid production growth and programme conversion |
| Defense software and hardware platform | 12× | $5.08bn | 18.2% | Recurring software economics plus scaled hardware |
| Exceptional strategic platform | 16× | $3.81bn | 11.6% | Rare margins, durable moat and strategic scarcity |
We track defense tech daily. Want the market signals in your inbox?
Send me the signals →Q10So, is Anduril really worth its valuation today?
No. Anduril is not fully worth $61 billion based only on the evidence visible today, but the valuation is much closer to defensible than the headline number suggests.
The company scores 54.3 out of 100 across our model. Its strongest areas are product proof, Lattice and operational validation. Its weakest are revenue quality, contract conversion and direct valuation support.
Current evidence supports approximately $29.4 billion, or 48.2% of the valuation. Explicit future options add $14.5 billion, while $23.7 billion remains dependent on additional growth, programme conversion and strategic premium.
Our base scenario produces a value of $55.1 billion, only 9.7% below the observed valuation. That case already assumes $4.3 billion of revenue, selective programme conversion, an on-time Arsenal and Fury ramp, several operational products and a broadly integrated Lattice platform.
The bear case falls to $24.4 billion if ceilings convert slowly, manufacturing remains thin and Lattice never develops strong software economics. The bull case reaches $93.1 billion only if CCA, Barracuda, NGC2 and major frameworks convert, mass production works and Lattice gains recurring economics plus independent performance proof.
We therefore classify Anduril as modestly overvalued today, but credibly capable of growing into the price. Investors are paying early for a company whose hardest industrial, financial and platform claims still need to be proven.
Anduril valuation scenarios
| Scenario | Revenue assumption | Core conditions | Implied valuation | Difference from $61bn |
|---|---|---|---|---|
| Bear | $3.2bn | Limited ceiling conversion, slower manufacturing and weak software economics | $24.4bn | -60.0% |
| Base | $4.3bn | Selective programme conversion, successful ramps and broad Lattice integration | $55.1bn | -9.7% |
| Bull | $5.2bn | Strong programme conversion, mass production and recurring Lattice economics | $93.1bn | +52.6% |
We track defense tech daily. Want the market signals in your inbox?
Send me the signals →We built the Anduril Valuation Proof Map from public evidence available at publication, separating what the company has demonstrated today from what still depends on future execution. We prioritized government procurement records, customer announcements, regulatory filings and official programme updates. We used Anduril’s own materials mainly for product specifications, acquisitions, manufacturing targets and technical claims that customers do not publish. Tier-one reporting filled the remaining gaps around private revenue, forecasts and valuations.
The 54.3 score summarizes the strength of the evidence across revenue, contracts, products, operational deployments, major programmes, manufacturing, Lattice, customers and valuation.
For contracts, we counted value as firm only when a public source identified an obligation, funded order or explicit commitment. Maximum ceilings, optional periods, purchasing frameworks and potential programme values remained in the opportunity pipeline rather than being treated as backlog.
We consolidated closely related variants into product families and assessed each family using the same maturity sequence, from testing and customer selection through delivery, operational deployment, repeat orders and verified production scale. We used the highest stage supported by public evidence, not the stage described in marketing language.
We selected programmes that could materially change Anduril’s revenue, production scale or strategic position. Resolved wins, losses, delays and setbacks were all retained. Unresolved opportunities were probability-weighted according to their procurement stage so that early competitions did not carry the same value as funded selections.
Where Anduril does not disclose revenue composition or customer concentration, we used directional midpoints derived from identifiable contracts, products, customer relationships and procurement exposure. These estimates describe the likely business mix rather than company-reported segment accounts.
We separated public defense incumbents from private defense-technology peers because the two groups test different versions of Anduril’s future. We used filed actual revenue for listed companies and clearly labeled forward estimates where private-company comparisons required them.
We assessed Lattice through deployment breadth, integration depth, customer evidence, independent validation and recurring software economics. Integration across Anduril’s portfolio counted as evidence of strategic value, but not automatically as proof of standalone software revenue.
Finally, the valuation bridge separated value supported by current evidence from value attached to future options. We applied a 15% overlap and execution haircut where Lattice, programme conversion and strategic scarcity could capture the same expected upside. The bear, base and bull cases then tested the revenue multiples Anduril could sustain under different future identities.
Key sources used for this analysis include: Anduril’s Series H announcement, the Financial Times on private defense-tech revenue multiples, the US Army on the ten-year enterprise contract, the US Department of Defense on the Marine Corps counter-UAS contract, the Air Force on the FQ-44 production award, the US Air Force on the initial CCA selection, the Australian Government on the Ghost Shark programme, JobsOhio on Arsenal-1 investment and employment targets, Anduril’s Arsenal-1 materials, Anduril’s official product portfolio, Anduril’s Lattice command-and-control documentation, the Lattice API documentation, NATO’s eAirC2 selection announcement.
Building or investing in defense technology?We can send you all the signals
Send me the signals → Delivered straight to your inbox